Altus Pharmaceuticals Inc. Intellectual Property Contracts & Agreements
4 Contracts & Agreements
- License Agreements (4 contracts)
- Ex-10.3 License Agreement dated February 20, 2009 by and between the Registrant and Cystic Fibrosis Foundation Therapeutics, Inc (Filed With SEC on May 11, 2009)
- EX-10.50 Manufacturing License Agreement (Amano Enzyme, Inc.) (Filed With SEC on March 11, 2008)
- EX-10.13 TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on January 11, 2006)
- Ex-10.13 Technology License Agreement, dated February 1, 1999, as amended (Filed With SEC on December 27, 2005)
